by Elena Iemma | Feb 23, 2024 | News
If you missed the posters that we presented at AAPS NBC 2024, don’t worry! Click each poster below to enlarge it or download. Have questions or interested in discussing these studies more? Send us a message here. An “I” (Immunogenicity Risk...
by Elena Iemma | Sep 12, 2022 | News
PROVIDENCE, RI, September 12, 2022 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) is pleased to announce the award of a two-year, $2 million grant from the FDA’s Office of Center for Drug Evaluation and Research (CDER) to validate a method for immunogenicity risk...
